Issue 1/2013
Content (8 Articles)
Review
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
Benjamin Lam, Mario Masellis, Morris Freedman, Donald T Stuss, Sandra E Black
Review
Alcohol-related dementia: an update of the evidence
Nicole J Ridley, Brian Draper, Adrienne Withall
Meeting report
Diverse therapeutic targets and biomarkers for Alzheimer's disease and related dementias: report on the Alzheimer's Drug Discovery Foundation 2012 International Conference on Alzheimer's Drug Discovery
Rachel F Lane, Penny A Dacks, Diana W Shineman, Howard M Fillit
Open Access
Research
18F-florbetaben Aβ imaging in mild cognitive impairment
Kevin Ong, Victor L Villemagne, Alex Bahar-Fuchs, Fiona Lamb, Gaël Chételat, Parnesh Raniga, Rachel S Mulligan, Olivier Salvado, Barbara Putz, Katrin Roth, Colin L Masters, Cornelia B Reininger, Christopher C Rowe
Open Access
Research
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
Carina Wattmo, Erik Jedenius, Kaj Blennow, Åsa K Wallin
Open Access
Research
Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy
Alireza Atri, José L Molinuevo, Ole Lemming, Yvonne Wirth, Irena Pulte, David Wilkinson
Open Access
Research
Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity
Steven Ferris, Jeffrey Cummings, Daniel Christensen, Rachelle Doody, Martin Farlow, Marwan Sabbagh, Liang Liu, Joan Mackell, Randi Fain